Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harrow Health Inc (HROW)
NASDAQ:HROW
Holding HROW?
Track your performance easily
HROW Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.13 - $59.23
Previous Close$34.22
Volume554.34K
Average Volume (3M)526.36K
Market Cap
$1.23B
Enterprise Value$1.35B
Total Cash (Recent Filing)$72.60M
Total Debt (Recent Filing)$196.06M
Price to Earnings (P/E)―
Beta1.88
Next Earnings
Mar 13, 2025EPS Estimate
$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.94
Shares Outstanding35,614,718
10 Day Avg. Volume440,902
30 Day Avg. Volume526,363
Standard Deviation0.21
R-Squared0.03
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)20.99
Price to Sales (P/S)7.25
Price to Cash Flow (P/CF)103.90
P/FCF Ratio130.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.08
Enterprise Value/Gross Profit14.90
Enterprise Value/Ebitda2.20K
Forecast
1Y Price Target
$62.00Price Target Upside81.18% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Harrow Health News
PremiumCompany Announcements
Harrow Inc. Reports Strong Q3 2024 Growth
Ownership Overview
24.03% Insiders
10.24% Mutual Funds
27.88% Other Institutional Investors
26.80% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HROW FAQ
What was Harrow Health Inc’s price range in the past 12 months?
Harrow Health Inc lowest stock price was $9.13 and its highest was $59.23 in the past 12 months.
What is Harrow Health Inc’s market cap?
Currently, no data Available
When is Harrow Health Inc’s upcoming earnings report date?
Harrow Health Inc’s upcoming earnings report date is Mar 13, 2025 which is in 81 days.
How were Harrow Health Inc’s earnings last quarter?
Harrow Health Inc released its earnings results on Nov 13, 2024. The company reported -$0.12 earnings per share for the quarter, missing the consensus estimate of -$0.052 by -$0.068.
Is Harrow Health Inc overvalued?
According to Wall Street analysts Harrow Health Inc’s price is currently Undervalued.
Does Harrow Health Inc pay dividends?
Harrow Health Inc does not currently pay dividends.
What is Harrow Health Inc’s EPS estimate?
Harrow Health Inc’s EPS estimate is $0.02.
How many shares outstanding does Harrow Health Inc have?
Harrow Health Inc has 35,614,720 shares outstanding.
What happened to Harrow Health Inc’s price movement after its last earnings report?
Harrow Health Inc reported an EPS of -$0.12 in its last earnings report, missing expectations of -$0.052. Following the earnings report the stock price went down -17.259%.
Which hedge fund is a major shareholder of Harrow Health Inc?
Among the largest hedge funds holding Harrow Health Inc’s share is Private Capital Management, LLC. It holds Harrow Health Inc’s shares valued at 97M.
---
Harrow Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$62.00 (81.18% Upside)
$62.00 (81.18% Upside)
Blogger Sentiment
Bullish
HROW Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 531.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 2.6%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
241.85%
12-Months-Change
Fundamentals
Return on Equity
-50.10%
Trailing 12-Months
Asset Growth
22.76%
Trailing 12-Months
Company Description
Harrow Health Inc
Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.
---
HROW Company Deck
---
HROW Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and strategic product launches, particularly with VEVYE and the retina pivot strategy. However, inventory issues with VEVYE and seasonal impacts on revenue were noted as challenges.Read More>---
HROW Stock 12 Month Forecast
Average Price Target
$62.00
▲(81.18% Upside)
Technical Analysis
EyePoint Pharmaceuticals
―
Ocular Therapeutix
―
Kala Pharmaceuticals
―
Kazia Therapeutics
―
Best Analysts Covering HROW
1 Year
1 Year Success Rate
10/15 ratings generated profit
1 Year Average Return
+115.85%
reiterated a buy rating 18 days ago
Copying Mayank Mamtani's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +115.85% per trade.
---